Search results for " DIABETES MELLITUS"

showing 9 items of 309 documents

Atherosclerosis: risk assessment and the role of aiming for optimal glycaemic control in young patients with type 1 diabetes

2023

Wprowadzenie: Dzieci z cukrzycą typu 1 (type 1 diabetes mellitus – DM1) mają w porównaniu ze zdrowymi rówieśnikami podwyższone ryzyko rozwoju zaawansowanej miażdżycy oraz choroby sercowo-naczyniowej (cardiovascular disease – CVD), a niedostateczna kontrola glikemii jest najważniejszym modyfikowalnym czynnikiem ryzyka CVD w DM1. Aktualne metody oceny kontroli glikemii to ocena hemoglobiny glikowanej (HbA1c), samokontrola glikemii za pomocą glukometru (SMBG), a także stosowanie systemów ciągłego monitorowania glukozy (CGM). Do pośredniej oceny ryzyka rozwoju CVD mogą służyć badania rozszerzenia tętnicy w odpowiedzi na niedokrwienie (flow-mediated dilatation – FMD) i prędkości fali tętna (PWV)…

miażdżycaIMTCGMcukrzyca typu 1atherosclerosisCVDtype 1 diabetes mellitusPediatric Endocrinology, Diabetes and Metabolism
researchProduct

Three-year mortality after acute myocardial infarction in patients with different diabetic status

2021

Introduction: The prevalence of diabetes mellitus (DM) in patients with myocardial infarction (MI) is estimated at about 25%. Short and long-term prognoses are worse in DM and hyperglycemia compared with non-diabetics. Objectives: Our aim was to analyze the impact of DM and transient hyperglycemia on in-hospital complications and long-term outcomes in MI patients. Patients and Methods: We evaluated a prospective cohort of 58,394 MI patients in the Polish Registry of Acute Coronary Syndrome in terms of in-hospital complications and 30-day, 12-month, and 36-month outcomes between 2009–2012. Results: Type 1 and 2 DM patients underwent invasive diagnostic and therapeutic procedures less frequen…

myocardial infarctionnew-onset diabetes mellitusdiabetes mellitusPLACS registryhyperglycemiaPolskie Archiwum Medycyny Wewnętrznej
researchProduct

New developments in the pathogenesis of obesity-induced hypertension

2015

Obesity is a disorder that develops from the interaction between genotype and environment involving social, behavioral, cultural, and physiological factors. Obesity increases the risk for type 2 diabetes mellitus, hypertension, cardiovascular disease, cancer, musculoskeletal disorders, chronic kidney and pulmonary disease. Although obesity is clearly associated with an increased prevalence of hypertension, many obese individuals may not develop hypertension. Protecting factors may exist and it is important to understand why obesity is not always related to hypertension. The aim of this review is to highlight the knowledge gap for the association between obesity, hypertension, and potential …

obesityhypertensionPhysiologyAppetiteDiseaseGut floraleptinDiabetes mellitusInternal Medicinemedicinea-MSHAnimalsHumanssaltEpigeneticsExercisesun lightsympathetic nervous systembiologygut microbiotabusiness.industryLeptinpotassiumPotassium DietaryType 2 Diabetes MellitusCancerSodium DietaryProtective Factorsmedicine.diseasebiology.organism_classificationObesityDiabetes Mellitus Type 2Cardiovascular DiseasesImmunologyReceptor Melanocortin Type 4Gene-Environment InteractionCardiology and Cardiovascular Medicinebusiness
researchProduct

Melatonin Concentrations and Sleep Quality in Patients with Type 2 Diabetes and Obesity

2019

Abstract There is a close relationship between melatonin as a circadian regulator and insulin, glucagon and somatostatin production. This study aimed to describe subgroups of type 2 diabetes mellitus (T2DM) patients that may benefit from melatonin clock-targeting properties. The study involved 38 participants: 26 T2DM patients, and 12 participants without diabetes in the control group. Subjects were asked to complete the questionnaire of Pittsburgh Sleep Quality Index (PSQI). Standard biochemical venous sample testing was performed, and a sample of saliva was collected for melatonin testing. Melatonin concentration in participants without obesity (body mass index (BMI) < 30 kg/m2) was si…

obesitymedicine.medical_specialtySciencemedicine.medical_treatmentmelatonin030209 endocrinology & metabolismType 2 diabetesGastroenterologyMelatoninPittsburgh Sleep Quality Index03 medical and health sciences0302 clinical medicineDiabetes mellitusInternal medicinemedicineMultidisciplinaryInsulinQType 2 Diabetes Mellitussleep qualitymedicine.diseaseObesitytype 2 diabetesBody mass index030217 neurology & neurosurgerymedicine.drugProceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
researchProduct

Comparative analysis of socioeconomic, behavioral and biological factors between healthy patients and patients with newly diagnosed diabetes in the L…

2020

Introduction. The most effective way to prevent a dramatic increase in the number of diabetic patients lies in early detection of its risk factors and the diagnosis of carbohydrate metabolism disorders. Aim of the study. The study aims at determining socio-economic variables, lifestyle behaviours and biological factors differentiating patients with newly diagnosed diabetes from the diabetes-free individuals according to the American criteria issued by the Commission on Social Determinants of Health as well as FINDRISC form which helps identify patients who are at risk of developing diabetes type 2 on the basis of multi-factorial determinants of its development. Material and methods. The res…

prediabetic statetype 2 diabetes mellituspatientsMedical Science Pulse
researchProduct

Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study a…

2017

Background Randomized controlled trials (RCTs) in the field of diabetes have limitations inherent to the fact that design, setting, and patient characteristics may be poorly transferrable to clinical practice. Thus, evidence from studies using routinely accumulated clinical data are increasingly valued. Aims We herein describe rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes), a multicenter retrospective nationwide study conducted at 50 specialist outpatient clinics in Italy and promoted by the Italian Diabetes Society. Data synthesis The primary objective of the study is to describe the baseline clinical characteristics (particularly HbA1c) of pa…

randomized controlled trial; real-life; retrospective study; sodium glucose co-transporter-2 inhibitor; medicine (miscellaneous); endocrinology; diabetes and metabolism; nutrition and dietetics; cardiology and cardiovascular medicineBlood GlucoseTime FactorsGlucosideGlycated Hemoglobin ATime FactorMedicine (miscellaneous)Settore MED/13 - EndocrinologiaEndocrinologyGlucosidesSodium-Glucose Transporter 2Retrospective StudieDiabetes MellitusHumansHypoglycemic AgentsData MiningBenzhydryl CompoundsRandomized controlled trial; Real-life; Retrospective study; Sodium glucose co-transporter-2 inhibitor; Benzhydryl Compounds; Biomarkers; Blood Glucose; Data Mining; Diabetes Mellitus Type 2; Glucosides; Glycated Hemoglobin A; Humans; Hypoglycemic Agents; Italy; Research Design; Retrospective Studies; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Treatment Outcome; Crowdsourcing; Evidence-Based Medicine; Medicine (miscellaneous); Endocrinology Diabetes and Metabolism; Nutrition and Dietetics; Cardiology and Cardiovascular MedicineSodium-Glucose Transporter 2 InhibitorsRetrospective StudiesGlycated HemoglobinBenzhydryl CompoundNutrition and DieteticsEvidence-Based MedicineHypoglycemic AgentSodium-Glucose Transporter 2 InhibitorRandomized controlled trial; Real-life; Retrospective study; Sodium glucose co-transporter-2 inhibitor; Benzhydryl Compounds; Biomarkers; Blood Glucose; Data Mining; Diabetes Mellitus Type 2; Glucosides; Glycated Hemoglobin A; Humans; Hypoglycemic Agents; Italy; Research Design; Retrospective Studies; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Treatment Outcome; Crowdsourcing; Evidence-Based MedicineReal-lifeBiomarkerDiabetes and MetabolismRandomized controlled trial; Real-life; Retrospective study; Sodium glucose co-transporter-2 inhibitor; Benzhydryl Compounds; Biomarkers; Blood Glucose; Data Mining; Diabetes Mellitus Type 2; Glucosides; Glycated Hemoglobin A; Humans; Hypoglycemic Agents; Italy; Research Design; Retrospective Studies; Sodium-Glucose Transporter 2; Time Factors; Treatment Outcome; Crowdsourcing; Evidence-Based Medicine; Medicine (miscellaneous); Endocrinology Diabetes and Metabolism; Nutrition and Dietetics; Cardiology and Cardiovascular MedicineRetrospective studyTreatment OutcomeDiabetes Mellitus Type 2ItalyRandomized controlled trialResearch DesignSodium glucose co-transporter-2 inhibitorCrowdsourcingCardiology and Cardiovascular MedicineBiomarkersType 2Human
researchProduct

Stroke patterns, etiology, and prognosis in patients with diabetes mellitus.

2005

stroke diabetes mellitus
researchProduct

Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: the Nurses' Health Study: response to Janghorbani et al

2007

stroke diabetes mellitus
researchProduct

Otrā tipa cukura diabēta pacientu līdzestība ārstēšanā un aprūpē

2020

Bakalaura darba tēma “Otrā tipa cukura diabēta pacientu līdzestība ārstēšanā un aprūpē”. Tēmas aktualitāti nosaka straujais cukura diabēta slimnieku skaita pieaugums pasaulē. Cukura diabēts ierindojas piektajā vietā pasaules izplatītāko mirstības cēloņu vidū, kā arī ir galvenais akluma, nieru mazspējas, infarkta, insulta un apakšējo ekstremitāšu amputācijas iemesls. Darba mērķis ir noskaidrot 2. tipa cukura diabēta pacientu līdzestību ārstēšanā un aprūpē. Pētījuma uzdevumi ir izpētīt zinātnisko literatūru par 2. tipa cukura diabētu un pacientu līdzestību ārstēšanās un atveseļošanās procesos. Raksturot Kalistas Rojas adaptācijas teoriju, un saistīt to ar pētījuma tēmu. Veikt pētījumu un inte…

type 2 diabetes mellitus2. tipa cukura diabētsadherencelīdzestībaMedicīna
researchProduct